Breaking News

Lander talks new, ‘more ambitious' Cancer Moonshot; Biden’s FDA pick vows to reform accelerated approvals

 

Daily Recap

STAT+: Lander: New cancer plan 'more ambitious by far' than original moonshot

By Lev Facher

Alex Wong/Getty Images

Biden’s science adviser says the latest Cancer Moonshot effort is “more ambitious by far” than the Obama administration’s first attempt.

Read More

STAT+: Biden's FDA pick Califf vows to reform accelerated approvals to win a key senator's support

By Nicholas Florko

Manuel Balce Ceneta/AP

Robert Califf promised a key senator that he will crack down on drug companies abusing the so-called accelerated approval pathway.

Read More

STAT+: How Andreessen Horowitz competes for the best health tech startups

By Mario Aguilar

julie yoo Andreessen Horowitz

Julie Yoo's experience co-founding a health tech company is a major selling point for startups considering funding from a16z.

Read More

Opinion: High-risk individuals should get priority access to Covid therapies. That isn't happening

By Caroline Behr and Michael L. Barnett

Craig F. Walker/Globe Staff

People at high risk of developing severe Covid-19 symptoms should have high priority for getting monoclonal antibodies. That isn't happening.

Read More

Opinion: Primary care clinicians are the glue to health and wellness. Their shortage spells trouble

By Deborah Cohen

Adam Berry/Getty Images

Two supply chain problems — the dwindling pipeline of primary care clinicians and poor support for primary care — threaten U.S. health care.

Read More

Opinion: Recovery community organizations need more than bake sales to help people survive addiction

By Ryan Hampton and William Stauffer

Ted S. Warren/AP

Recovery community organizations are key drivers of the recovery movement yet rarely get credit — or funding — for the work they do.

Read More

Friday, February 4, 2022

STAT

Facebook   Twitter   YouTube   Instagram

1 Exchange Pl, Suite 201, Boston, MA 02109
©2022, All Rights Reserved.
I no longer wish to receive STAT emails
Update Email Preferences | Contact Us | View In Browser

No comments